Investment analysts at StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “buy” rating on the stock.
Trinity Biotech Stock Performance
NASDAQ:TRIB opened at $0.72 on Tuesday. The business’s fifty day moving average is $0.87 and its 200 day moving average is $0.94. The firm has a market cap of $27.44 million, a price-to-earnings ratio of -0.77 and a beta of 1.45. Trinity Biotech has a 52-week low of $0.63 and a 52-week high of $1.41.
Trinity Biotech (NASDAQ:TRIB – Get Free Report) last posted its earnings results on Thursday, July 6th. The company reported ($0.16) earnings per share for the quarter. Trinity Biotech had a negative net margin of 48.76% and a negative return on equity of 870.11%. The company had revenue of $14.83 million for the quarter. Equities analysts predict that Trinity Biotech will post -0.4 EPS for the current fiscal year.
Institutional Investors Weigh In On Trinity Biotech
About Trinity Biotech
Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
- Five stocks we like better than Trinity Biotech
- The How and Why of Investing in Biotech Stocks
- MarketBeat Week in Review – 8/28 – 9/1
- Trading Stocks: RSI and Why it’s Useful
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What is the Dow Jones Industrial Average (DJIA)?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Trinity Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Biotech and related companies with MarketBeat.com's FREE daily email newsletter.